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Introduction
The patients characterized with chronic subclinical
inflammation even during attack-free periods, are now
considered to have an increased risk of atherosclerotic
complications as well as other autoinflammatory disease.
Damage to the arterial wall due to atherosclerosis causes
increased arterial stiffness. Pulse wave velocity (PWV), a
noninvasive measure of arterial stiffness, is accepted to be
an indicator of subclinical atherosclerosis. Cardiovascular
disease included various risk markers; blood biomarkers
and genetic markers.
Matrix metalloproteinases (MMPs) are closely related
proteinases that together are able to degrade all macromo-
lecules of the extracellular matrix. MMPs are potentially
implicated in atherogenesis, progression of atherosclerosis.
The gene encoding MMP-3 is polymorphic and an inser-
tion (6A)/deletion (5A) polymorphism (5A/6A polymorph-
ism) in the MMP-3 gene may have functional significance
in the regulation of its expression. The 5A allele was
associated with higher and the 6A allele with lower
transcriptional activity. Up to date, the 6A/6A and 5A/6A
genotypes were associated with coronary artery disease
and carotid atherosclerosis in adults.
Objectives
We aimed to evaluate the effect of inflammation and the
strength of association MMP-3 promoter low- and high-
activity genotypes on the increased risk of subclinical
atherosclerosis in FMF patients.
Methods
Forty-seven patients (M/F =21/26) with FMF, and 50 age-
and sex-matched controls were recruited. We measured
lipid profile (LDL, total cholesterol and lipoprotein a
level) and acute phase reactants (APRs) (white blood
cells, erythrocyte sedimentation rate, high sensitive
C-Reactive Protein and Serum Amyloid A) in attack free
period of all patients. Aortic PWV was determined by
using an automatic device (Vicorder, Germany) that
allowed on-line pulse wave recording and automatic calcu-
lation of the PWV. The 5A/6A polymorphism was typed
by RFLP-PCR.
Results
The mean APRs values were not found statistically signifi-
cant in patients than control. The distribution of the
genotypes of the 5A/6A polymorphism in both control and
study patients did not differ significantly (40%,32.8% ,
respectively p>0.05) from those predicted by the Hardy-
Weinberg distribution.
The PWV was slightly higher in patients with FMF than
in control subjects (P=0.05). Fifteen patients (32%) have
PWV values above the average. These patients have also
high SAA and lipoprotein-a levels in attack free period.
A significant correlation between PWV and lipoprotein
a (P<0.001, r=0.67), and SAA level (P<0.001, r=0.52) was
found in patients with FMF. There was no detected
hypertension. There were no significant differences
(p>0.05) in genotype distributions (hyperlipidemia and
arterial stiffness index) and allele frequencies between
subgroups.
Conclusion
The results showed that arterial stiffness is correlated with
hyperlipidemia and subclinical inflammation in FMF
patients. But, the 5A/6A polymorphism of MMP-3 gene
may not be linked with appearance and/or progression of
arterial stiffness in FMF patients. Our suggestion is that
SAA levels as well as the use of therapy monitoring can be
predict in cardiovascular disease in patients with FMF.
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